NCR3 and non-small cell lung carcinoma: To investigate the involvement of NKp30 in the recognition and cytolysis of lung cancer cells by NK cells, we utilized the soluble ligand B7H6 to preemptively inhibit NKp30 function, followed by assessment of the cytotoxic activity of NK92 cells against a NSCLC cell line.